Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xab8
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 78M | $110M | -1% | Sep 2025 |
|
| Weiss Asset Management LP[1 | 68M | $95M | 0% | Sep 2025 |
|
| Wolverine Asset Management | 46M | $86M | -49% | Dec 2025 |
|
| Tenor Capital Management | 30M | $42M | 0% | Sep 2025 |
|
| Citadel Advisors | 29M | $41M | -15% | Sep 2025 |
|
| Graham Capital Management | 26M | $36M | -56% | Sep 2025 |
|
| Balyasny Asset Management | 25M | $35M | 100% | Sep 2025 |
|
| Ing Investment Management | 24M | $34M | 9% | Sep 2025 |
|
| Capstone Investment Advisors | 24M | $34M | 100% | Sep 2025 |
|
| Lazard Asset Management | 23M | $329k | -53% | Sep 2025 |
|
| 683 Capital Management | 22M | $30M | -12% | Sep 2025 |
|
| Lord, Abbett & Co | 11M | $16M | -1% | Sep 2025 |
|
| M&G | 10M | $15M | 0% | Sep 2025 |
|
| State Street Corporation | 10M | $14M | 5% | Sep 2025 |
|
| Millennium Management | 10M | $14M | 0% | Sep 2025 |
|
| FMR | 6.3M | $8.8M | -5% | Sep 2025 |
|
| Aristeia Capital | 6.0M | $8.4M | 100% | Sep 2025 |
|
| BlackRock | 5.3M | $7.4M | -1% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 3.0M | $5.7M | -32% | Dec 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $4.2M | 50% | Sep 2025 |
|
| RWC Asset Management | 2.2M | $3.0M | -10% | Sep 2025 |
|
| AXA Investment Managers | 1.9M | $2.6M | 100% | Sep 2025 |
|
| Oaktree Capital Management | 1.9M | $2.6M | -12% | Sep 2025 |
|
| Man Group | 1.4M | $1.9M | -19% | Sep 2025 |
|
| Union Bancaire Privee, UBP SA | 1.1M | $1.8M | 110% | Dec 2025 |
|
| Agf Management | 1.0M | $1.4M | 0% | Sep 2025 |
|
| Palisade Capital Management | 914k | $1.3M | 0% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 793k | $1.1M | 52% | Sep 2025 |
|
| SSI Investment Management | 581k | $815k | 45% | Sep 2025 |
|
| Calamos Advisors | 493k | $931k | -91% | Dec 2025 |
|
| GAMCO Asset Management | 300k | $566k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 300k | $567k | 0% | Dec 2025 |
|
| Advent Capital Management | 300k | $422k | 35% | Sep 2025 |
|
| Jpmorgan Chase & Co | 299k | $418k | 100% | Sep 2025 |
|
| Nomura Holdings | 295k | $15M | -40% | Sep 2025 |
|
| Royal Bank of Canada | 286k | $286k | -86% | Sep 2025 |
|
| Russell Investments | 160k | $225k | 0% | Sep 2025 |
|
| Calamos Wealth Management | 61k | $115k | 2% | Dec 2025 |
|
| SG Americas Securities | 60k | $11M | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 20k | $2.8M | -99% | Sep 2025 |
|
| Barclays | 16k | $22k | 100% | Sep 2025 |
|
| Stonegate Investment Group | 16k | $22k | 0% | Sep 2025 |
|
| Traub Capital Management | 10k | $19k | 0% | Dec 2025 |
|
| Pnc Financial Services | 2.0k | $377k | 0% | Dec 2025 |
|
| UBS Group | 1.0k | $1.9k | 100% | Dec 2025 |
|
| Jones Financial Companies, L.L | 1.0k | $1.4k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 1.0k | $1.4k | -100% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 1.0k | $1.4k | 100% | Sep 2025 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Amundi | Jun 2025 | 1.5M | $1.9M |
| Shenkman Capital Management | Sep 2025 | 491k | $691M |
| Toronto-Dominion Bank | Jun 2025 | 254k | $317k |